Please assess the completion status of the following clinical trial:

Trial Title: Impact of a Digital Self-Management Program on A1C for Individuals With Type 2 Diabetes

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults at least 18 years of age and less than 65 years of age~* Overweight (BMI ≥ 25 kg/m2, or BMI ≥ 23 kg/m2 if of Asian descent)~* Uncontrolled type 2 diabetes (HbA1C ≥7.5% and ≤12%)~* Diagnosed with type 2 diabetes at least 6 months ago, but not more than 10 years ago~* Has a compatible smartphone running either Android Operating System 5.0 or higher, or iPhone 7 or later, running iOS 11 or higher.~* Willing to set up an online account~* An email address in regular use~* Ambulatory (e.g., living at home and not in a skilled nursing facility)~* Able to speak, understand, and read English~Exclusion Criteria:~* A diagnosis of Type 1 diabetes~* Currently pregnant or postpartum (within 4 weeks)~* Currently using a continuous glucose monitor to manage diabetes~* Known allergy to medical grade adhesive or isopropyl alcohol used to disinfect skin~* Skin lesions, scarring, redness, infection or edema at the continuous glucose monitor application sites (upper arm) that could interfere with sensor placement or the accuracy of interstitial glucose measurements~* An active eating disorder such as anorexia or bulimia (not including binge-eating disorder) for which he/she has received treatment in the past 12 months~* Alcohol or substance abuse that impairs ability to participate in the program~* Unable to engage in physical activity for more than 2 months over the next 6 months (i.e. due to injury or recent or planned surgery)~* Any of the following in the past 3 months AND are not medically cleared by your physician to exercise: Transient ischemic attack or stroke; Heart attack (myocardial infarction); Hospitalization for congestive heart failure; Cardiac surgery (such as coronary artery bypass grafting (CABG), coronary artery stenting); Bariatric/gastric bypass surgery~* Received a solid Organ Transplant (kidney, liver, etc.) within the past 6 months~* Recent (within the last 6 months) or planned cancer treatment (chemotherapy, radiation, bone marrow transplant, cancer-related surgery - not including hormonal chemotherapy, such as tamoxifen).~* On dialysis treatment~* Taking steroids or prednisone (high doses) or getting cortisone injection~* Stage 4-5 Chronic Kidney Disease~* Class 3-4 Congestive Heart Failure~* Participation in diabetes education in the last 30 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Online Diabetes Self-Management Education and Support (DSMES) Program (Type: EXPERIMENTAL): Participants will receive access to a 6-month online DSMES program that includes several components that are standard to DSMES. Participants receive online curriculum, access to a live Certified Diabetes Care and Education Specialist (CDCES), interactive group message forums, and connected devices for monitoring food intake, weight, physical activity and glucose levels.
- Matched Control (Type: NO_INTERVENTION): A de-identified dataset of control subjects matched on baseline demographics and clinical characteristics will be cultivated for comparison to the active intervention arm.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: lack of efficacy